Event Videos

Use of Lactobacillus casei rhamnosus to Prevent Cholangitis in Biliary Atresia After Kasai Operation

http://www.ncbi.nlm.nih.gov/pubmed/25534776
(http://www.childrenliverindia.org/diseases/term/46)

Lien TH, Bu LN, Wu JF, Chen HL, Chen AC, Lai MW, Shih HH, Lee IH, Hsu HY, Ni YH, Chang MH. Use of Lactobacillus casei rhamnosus to Prevent Cholangitis in Biliary Atresia After Kasai Operation. J Pediatr Gastroenterol Nutr. 2015 May; 60(5):654-8.

Abstract

OBJECTIVES:
Recurrent cholangitis may aggravate cholestatic liver cirrhosis in biliary atresia (BA) after the Kasai operation. This pilot study aimed to investigate whether Lactobacillus casei rhamnosus has the prophylactic efficacy for recurrent cholangitis in comparison with the conventional neomycin prophylaxis.

METHODS:

Published on: 
May-2015
Read more

Financial support for vaccination in India till 2020: Gavi

Surce : http://zeenews.india.com/news/health/health-news/financial-support-for-v...

India will continue to get financial assistance from Gavi, a global alliance for vaccination and immunisation, only till 2020 because as the country develops it will have to pay for its vaccines.

Switzerland-based Gavi is on a drive to increase its global immunisation programme in which India has been an important partner.

"India is getting to a point where it will enter the period of graduating from Gavi's support, probably in 2016," Gavi Chief Executive Officer Seth Berkley told PTI.

Read more

Acute upper gastrointestinal bleeding in childhood: development of the sheffield scoring system to predict need for endoscopic therapy

http://www.ncbi.nlm.nih.gov/pubmed/25539193

- [EHPVO (http://www.childrenliverindia.org/diseases/term/96)]

Thomson MA, Leton N, Belsha D. Acute upper gastrointestinal bleeding in childhood: development of the sheffield scoring system to predict need for endoscopic therapy. J Pediatr Gastroenterol Nutr. 2015 May; 60(5):632-6.

Abstract

BACKGROUND/AIMS:
Upper gastrointestinal bleeding (UGIB) is a rare and potentially life-threatening condition in childhood. In adults with UGIB, validated scoring systems exist, but these are not applicable to children. The aim of this study was to construct a clinical scoring system to accurately predict the need for endoscopic haemostatic intervention.

METHODS:

Published on: 
May-2015
Read more

List of Pediatric Gastroenterologist India



Chandigarh



Dr. BR Thapa

Professor and Head,

Division of Pediatric Gastroenterology, Hepatology and nutrition,

PGIMER, Chandigarh



Delhi



Dr. Seema Alam

Additional Professor

Department of Pediatric Hepatology

Institue of Liver and Billiary Sciences,

New Delhi



Dr. Dinesh Rawat

Department of Pediatric Hepatology

Institue of Liver and Billiary Sciences,

New Delhi



Dr. Anupam Sibal

Read more

Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease

http://www.ncbi.nlm.nih.gov/pubmed/25493346

Pusateri AJ, Kim SC, Dotson JL, Balint JP, Potter CJ, Boyle BM, Crandall WV. Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015 May; 60(5):592-7.

Abstract

OBJECTIVES:
Patients with inflammatory bowel disease (IBD) often develop elevated liver enzymes (ELE), which are frequently a benign, transient finding, but may be related to treatment or IBD-associated liver diseases. Distinguishing benign from pathologic ELE is crucial for focused diagnostic and therapeutic interventions. We sought to characterize the incidence, character, chronicity, degree, and etiology of ELE in children with IBD.

METHODS:

Published on: 
May-2015
Read more

Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study

http://www.ncbi.nlm.nih.gov/pubmed/25874510

Rengasamy S, Ali SM, Sistla SC, Lakshmi CP, Harichandra Kumar KT. Comparisonof 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study. Eur J GastroenterolHepatol. 2015; 27(4):386-92.

Abstract

BACKGROUND:

Published on: 
Apr-2015
Read more

Extra Hepatic Portal Venous Obstruction (EHPVO)

 

FAQ on Extra Hepatic Portal Venous Obstruction (EHPVO)

 

1.     What is EHPVO?

 

EHPVO is a condition in which there is a block of the major vessel that supplies blood to the liver i.e. the portal vein.  This vein carries all absorbed nutrients from intestines to liver for storage and further metabolism. It accounts for major (80%) of blood supply to liver. Any block in this vein especially in the portion of the vein located outside the liver causes a condition called as EHPVO.

 

2.     What causes EHPVO?

EHPVO or the block in the portal vein may be caused by:

Read more

Occult hepatitis B infection in children with chronic liver disease

http://www.ncbi.nlm.nih.gov/pubmed/25874508

Srivastava A, Mathias A, Yachha SK, Aggarwal R. Occult hepatitis B infectionin children with chronic liver disease. Eur J GastroenterolHepatol. 2015; 27(4):375-7.

Abstract

AIMS:

Occult hepatitis B infection (OBI) may adversely affect the outcome of patients with chronic liver disease (CLD). There are no data on OBI and CLD in children. This study determined the prevalence and effect of OBI in HBsAg-negative CLD children.

MATERIALS AND METHODS:

CLD children were prospectively evaluated with a demographic, clinical, and investigative proforma. All HBsAg-negative CLD cases were tested for exposure to hepatitis B (total anti-HBc, anti-HBs). Serum hepatitis B virus DNA was measured in exposed (total anti-HBc positive) patients.

Published on: 
Apr-2015
Read more
« first ‹ previous … 132 133 134 135 136 137 138 139 140 … next › last »

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: